This user was banned for violating the House Rules. The ban is for social activity only - participating in public chats, publishing ideas, commenting and so on. The ban has no effect on the functionality of the platform.
-Top executive for Allergen , the creator of Botox, left the company to become CEO in May 2018, days before the de facto FDA approval
-More than 200 physician KOLs are invested in Evolus's parent company
-First 900 kDa neurotoxin to be filed with the FDA since Botox
-DPW-450 is projected to be 20-25% cheaper then Botox
-Approved by the FDA recently
-Massive...
Market Cap
2.86B
Enterprise Value
1.94B
Price/Sales
484.27
I think it is getting a little too far ahead of itself at this point. The Cramer pump is suspicious, especially considering the timing.
The reason I'm only adding 1/4th is because the momentum is still strong, and it could rally up to $20.00.